AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 12.326
NA - Nord America 6.312
EU - Europa 2.320
SA - Sud America 903
AF - Africa 69
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.991
Nazione #
HK - Hong Kong 9.007
US - Stati Uniti d'America 6.175
SG - Singapore 1.595
CN - Cina 739
BR - Brasile 725
IT - Italia 416
VN - Vietnam 405
RU - Federazione Russa 404
UA - Ucraina 350
DE - Germania 302
IE - Irlanda 217
TR - Turchia 186
SE - Svezia 156
KR - Corea 145
GB - Regno Unito 119
EE - Estonia 107
AR - Argentina 73
CA - Canada 73
FI - Finlandia 73
IN - India 55
BD - Bangladesh 38
MX - Messico 36
EC - Ecuador 35
PL - Polonia 33
FR - Francia 32
JP - Giappone 32
AU - Australia 30
ID - Indonesia 24
NZ - Nuova Zelanda 24
ZA - Sudafrica 21
ES - Italia 19
IQ - Iraq 19
NL - Olanda 18
CZ - Repubblica Ceca 17
VE - Venezuela 17
CO - Colombia 14
PK - Pakistan 14
PY - Paraguay 13
AT - Austria 11
KE - Kenya 11
CL - Cile 10
UZ - Uzbekistan 10
MA - Marocco 9
IL - Israele 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
AL - Albania 6
LT - Lituania 6
NP - Nepal 6
AZ - Azerbaigian 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
JO - Giordania 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
HR - Croazia 3
ME - Montenegro 3
MN - Mongolia 3
OM - Oman 3
PA - Panama 3
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MR - Mauritania 1
Totale 21.978
Città #
Hong Kong 8.995
Ann Arbor 1.105
Singapore 725
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Dallas 405
Ashburn 355
San Jose 341
Houston 255
Dublin 204
Woodbridge 201
Izmir 166
Beijing 160
Dong Ket 136
Nanjing 112
Moscow 110
Tallinn 107
Andover 104
Ho Chi Minh City 87
Boardman 86
The Dalles 73
Hanoi 70
São Paulo 70
Salerno 69
Munich 65
Los Angeles 64
Pellezzano 64
Düsseldorf 55
Norwalk 53
Dearborn 44
Shenyang 43
New York 40
Nanchang 39
Naples 37
Fairfield 34
Mestre 34
Hebei 29
Rio de Janeiro 27
Redwood City 26
Warsaw 26
Jiaxing 25
San Francisco 25
Montreal 24
Changsha 21
Rome 21
Santa Clara 21
Nuremberg 18
Pune 18
Tianjin 18
Boston 17
Brooklyn 17
Council Bluffs 17
Haiphong 17
Tokyo 17
Milan 16
Poplar 16
San Diego 16
Washington 16
Chennai 15
Atlanta 14
Casoria 14
Guarulhos 14
Stockholm 14
Ankara 13
Belo Horizonte 13
Denver 13
Turku 13
Amsterdam 12
Brasília 12
Curitiba 12
London 12
Phoenix 12
Porto Alegre 12
Seoul 12
Auckland 11
Frankfurt am Main 11
Guangzhou 11
Guayaquil 11
Nairobi 11
Orem 11
Quito 11
Seattle 11
Sydney 11
Campinas 10
Columbus 10
Dhaka 10
West Jordan 10
Tashkent 9
Baghdad 8
Cape Town 8
Chicago 8
Johannesburg 8
Manchester 8
Ribeirão Preto 8
Salvador 8
Wuhan 8
Cambridge 7
Carapicuíba 7
Totale 17.313
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 970
Sex Differences in Parkinson’s Disease: From Bench to Bedside 634
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 590
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 582
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 529
Gender differences in microRNA expression in levodopa-naive PD patients 525
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 503
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 489
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 418
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 412
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 377
The most effective way to obtain long-term memory is to increase first presentation duration of single words 353
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 312
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 298
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 277
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 271
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 262
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 254
Classifying Different Stages of Parkinson’s Disease Through Random Forests 247
Metabolomics in Parkinson's disease 240
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 229
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 211
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 204
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 195
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 192
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 182
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 180
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 178
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 170
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 166
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 161
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 156
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 155
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 151
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 146
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 144
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 144
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 137
Increased bilirubin levels in de novo Parkinson's disease 136
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 134
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 132
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 130
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 128
Quitting smoking: An early non-motor feature of Parkinson's disease? 127
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 124
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 124
Machine learning can predict mild cognitive impairment in Parkinson's disease 120
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 120
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 120
Abnormal eating behaviors in progressive supranuclear palsy. 119
Clinical and neurological abnormalities in adult celiac disease. 119
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 119
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 118
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 117
Freezing of gait and executive functions in patients with Parkinson’s disease 117
Bisphenol A glucuronidation in patients with Parkinson's disease 115
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 114
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 111
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 110
Gender and non motor fluctuations in Parkinson's disease: A prospective study 108
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 107
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 103
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 102
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 100
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 99
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 99
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 97
“Response to Apomorphine in early Parkinson’s disease”. 97
Cognitive correlates of “pure apathy” in Parkinson's disease 97
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 96
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 96
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 95
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 95
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 94
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 93
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 92
Uric acid relates to dopamine transporter availability in Parkinson's disease. 91
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 91
Parkinson’s disease and the spectrum of Lewy body disease 91
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 90
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 89
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 89
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 88
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 88
Resting brain networks in patients with Parkinson's disease and freezing of gait 87
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 86
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 85
The "eye of the tiger" sign in pure akinesia with gait freezing. 85
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 85
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 84
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 84
Gait patterns and cognition in Parkinson's disease 84
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 83
Cognitive contributions to gait and falls: Evidence and implications 82
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 81
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 81
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 80
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 80
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease 79
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 78
Totale 17.909
Categoria #
all - tutte 66.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 0 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202612.727 1.587 4.538 3.992 682 920 437 571 0 0 0 0 0
Totale 22.388